These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21477373)

  • 1. (-)-Pentazocine induces visceral chemical antinociception, but not thermal, mechanical, or somatic chemical antinociception, in μ-opioid receptor knockout mice.
    Ide S; Minami M; Uhl GR; Satoh M; Sora I; Ikeda K
    Mol Pain; 2011 Apr; 7():23. PubMed ID: 21477373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abolished thermal and mechanical antinociception but retained visceral chemical antinociception induced by butorphanol in mu-opioid receptor knockout mice.
    Ide S; Minami M; Ishihara K; Uhl GR; Satoh M; Sora I; Ikeda K
    Neuropharmacology; 2008 Jun; 54(8):1182-8. PubMed ID: 18417173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentazocine-induced antinociception is mediated mainly by μ-opioid receptors and compromised by κ-opioid receptors in mice.
    Shu H; Hayashida M; Arita H; Huang W; Zhang H; An K; Wu G; Hanaoka K
    J Pharmacol Exp Ther; 2011 Aug; 338(2):579-87. PubMed ID: 21543510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thienorphine induces antinociception without dependence through activation of κ- and δ-, and partial activation of μ- opioid receptor.
    Zhou P; Li Y; Yong Z; Chen M; Zhang Y; Su R; Gong Z
    Brain Res; 2020 Dec; 1748():147083. PubMed ID: 32871137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mu opioid receptor-dependent and independent components in effects of tramadol.
    Ide S; Minami M; Ishihara K; Uhl GR; Sora I; Ikeda K
    Neuropharmacology; 2006 Sep; 51(3):651-8. PubMed ID: 16793069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Buprenorphine antinociception is abolished, but naloxone-sensitive reward is retained, in mu-opioid receptor knockout mice.
    Ide S; Minami M; Satoh M; Uhl GR; Sora I; Ikeda K
    Neuropsychopharmacology; 2004 Sep; 29(9):1656-63. PubMed ID: 15100703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
    Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose pentazocine antagonizes the antinociception induced by high-dose morphine.
    Shu H; Wang Z; Ye F; Li Q; Dou Y; Lin Y; Huang W; Xiao X
    Life Sci; 2015 Jun; 130():1-6. PubMed ID: 25817230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of dezocine, pentazocine and tapentadol on antinociception and physical dependence.
    Ahsan MZ; Zhao MJ; Shoaib RM; Zhang Y; Wang YX
    Life Sci; 2021 Nov; 285():119996. PubMed ID: 34597607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen facilitates and the kappa and mu opioid receptors mediate antinociception produced by intrathecal (-)-pentazocine in female rats.
    Robinson DL; Nag S; Mokha SS
    Behav Brain Res; 2016 Oct; 312():163-8. PubMed ID: 27312267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent antinociceptive effects of TRK-820, a novel kappa-opioid receptor agonist.
    Endoh T; Matsuura H; Tajima A; Izumimoto N; Tajima C; Suzuki T; Saitoh A; Suzuki T; Narita M; Tseng L; Nagase H
    Life Sci; 1999; 65(16):1685-94. PubMed ID: 10573186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-cyclobutylmethyl analog of normorphinone, N-CBM-TAMO: a short-term opioid agonist and long-term Mu-selective irreversible opioid antagonist.
    Xu JY; Seyed-Mozaffari A; Archer S; Bidlack JM
    J Pharmacol Exp Ther; 1996 Nov; 279(2):539-47. PubMed ID: 8930155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antinociceptive activities and mechanism of action of Cepharanthine.
    Wei XY; Long JD; Chai JR; Chen J; Gao JP; Wang YJ; Liu JG
    Biochem Biophys Res Commun; 2022 Jul; 614():219-224. PubMed ID: 35636221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role for μ-opioid receptor in antidepressant effects of δ-opioid receptor agonist KNT-127.
    Moriya Y; Kasahara Y; Shimada M; Sakakibara Y; Fujii H; Nagase H; Ide S; Ikeda K; Hall FS; Uhl GR; Sora I
    J Pharmacol Sci; 2023 Mar; 151(3):135-141. PubMed ID: 36828615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of delta-opioid receptor contributes to the antinociceptive effect of oxycodone in mice.
    Yang PP; Yeh GC; Yeh TK; Xi J; Loh HH; Law PY; Tao PL
    Pharmacol Res; 2016 Sep; 111():867-876. PubMed ID: 27496654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel 2',6'-dimethyl-L-tyrosine-containing pyrazinone opioid mimetic mu-agonists with potent antinociceptive activity in mice.
    Jinsmaa Y; Okada Y; Tsuda Y; Shiotani K; Sasaki Y; Ambo A; Bryant SD; Lazarus LH
    J Pharmacol Exp Ther; 2004 Apr; 309(1):432-8. PubMed ID: 14718580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of mu-opioid receptor in mice does not affect the minimum alveolar concentration of volatile anaesthetics and nitrous oxide-induced analgesia.
    Koyama T; Mayahara T; Wakamatsu T; Sora I; Fukuda K
    Br J Anaesth; 2009 Nov; 103(5):744-9. PubMed ID: 19767313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. dextro- and levo-morphine attenuate opioid delta and kappa receptor agonist produced analgesia in mu-opioid receptor knockout mice.
    Wu HE; Sun HS; Terashivili M; Schwasinger E; Sora I; Hall FS; Uhl GR; Tseng LF
    Eur J Pharmacol; 2006 Feb; 531(1-3):103-7. PubMed ID: 16445907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of mu-opioid receptors in inflammatory hyperalgesia and alpha 2-adrenoceptor-mediated antihyperalgesia.
    Mansikka H; Zhou L; Donovan DM; Pertovaara A; Raja SN
    Neuroscience; 2002; 113(2):339-49. PubMed ID: 12127091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro binding affinities of a series of flavonoids for μ-opioid receptors. Antinociceptive effect of the synthetic flavonoid 3,3-dibromoflavanone in mice.
    Higgs J; Wasowski C; Loscalzo LM; Marder M
    Neuropharmacology; 2013 Sep; 72():9-19. PubMed ID: 23624290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.